Prognostic value of International Neuroblastoma Pathology Classification in localized resectable peripheral neuroblastic tumors: a histopathologic study of localized neuroblastoma European Study Group 94.01 Trial and Protocol.

@article{Navarro2006PrognosticVO,
  title={Prognostic value of International Neuroblastoma Pathology Classification in localized resectable peripheral neuroblastic tumors: a histopathologic study of localized neuroblastoma European Study Group 94.01 Trial and Protocol.},
  author={Samuel Navarro and G Paixo von Amann and Klaus Beiske and Catherine J Cullinane and Emanuele Stefano Giovanni D'Amore and Claudio Gambini and V{\'e}ronique Mosseri and Bruno De Bernardi and Jean-Louis. Michon and Michel Peuchmaur},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2006},
  volume={24 4},
  pages={
          695-9
        }
}
PURPOSE To assess the prognostic value of clinical, biologic, and morphologic data in peripheral neuroblastic tumors, International Neuroblastoma Staging System (INSS) stages 2A and 2B MYCN nonamplified, a multinational protocol entitled Localized Neuroblastoma European Study Group trial 94.01, with a trial of surgery as the only treatment, was initiated in 1995. We present the prognostic value of the revised International Neuroblastoma Pathology Classification (INPC) applied to the patients… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 18 CITATIONS

Identification of novel prognostic markers in relapsing localized resectable neuroblastoma.

  • Omics : a journal of integrative biology
  • 2011
VIEW 2 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Similar Papers